Table 1 Relationship between patient intratumor Cul4B and clinicopathologic features
From: Cul4B promotes the progression of ovarian cancer by upregulating the expression of CDK2 and CyclinD1
| Variable | Intratumor Cul4B | ||
|---|---|---|---|
| Low expression (n = 64) | High expression (n = 64) | p | |
| Age (years) | |||
| < 50 | 13 | 21 | 0.109 |
| ≥50 | 51 | 43 | |
| Pathological type | |||
| Non-serous tumour | 37 | 32 | 0.375 |
| Serous tumour | 27 | 32 | |
| Tumor grade | |||
| 1 | 10 | 9 | 0.804 |
| 2–3 | 54 | 55 | |
| Tumor size | |||
| < 10 cm | 24 | 25 | 0.856 |
| ≥10 cm | 40 | 39 | |
| FIGO | |||
| I-II | 50 | 39 | 0.035 |
| III-IV | 14 | 25 | |
| CA125 | |||
| < 70 U/L | 27 | 29 | 0.581 |
| ≥70 U/L | 36 | 35 | |
